Immunomodulators; used in the treatment of covid-19
Author(s):
A Pandey, Shalu
Keywords:
SARS-CoV-2, ILS, CRS, TNF
Abstract
The novel coronavirus pandemic has emerged as one of the significant medical-health challenges of the current century. The World Health Organization has named this new virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Immumomodulators may effectively treat patients and reduce mortality rates. Various therapeutic compounds have been investigated and applied to mitigate the symptoms in COVID-19 patients and cure the disease. These drugs consist of IL-1, IL-6, and immunosuppressive. There is emerging data that immunomodulatory drugs could be protective at reducing certain features of SARS-CoV-2 and improving recovery. In this article we will discuss potential treatment options for SARS-CoV-2 using immunomodulatory drugs and at what stage of the condition they may be beneficial.
Article Details
Unique Paper ID: 156537
Publication Volume & Issue: Volume 9, Issue 4
Page(s): 123 - 133
Article Preview & Download
Share This Article
Conference Alert
NCSST-2023
AICTE Sponsored National Conference on Smart Systems and Technologies
Last Date: 25th November 2023
SWEC- Management
LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT